A carregar...
Immunotherapeutic Targets and Therapy for Renal Cell Carcinoma
Over the last 20 years, different therapies have been considered as the mainstay for the treatment of patients with metastatic renal cell carcinoma (mRCC). Since angiogenesis is a key mechanism in the pathogenesis of renal carcinoma, research is still focusing on the inhibition of new vessel growth...
Na minha lista:
| Publicado no: | Immunotargets Ther |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7671463/ https://ncbi.nlm.nih.gov/pubmed/33224904 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S240889 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|